Interim COVID-19 vaccination coverage in the EU/EEA during the 2023-24 season campaigns : January 2024

In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023-24 season vaccination campaigns. This report presents an interim description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and January 2024. - During the reporting period, 24/30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, individuals with chronic conditions, pregnant women). - During this period, approximately 19.4 million people aged 60 years and above received one COVID-19 vaccine dose. Approximately 5.5 million people aged 80 years and above received one COVID-19 vaccine dose. - The median COVID-19 vaccination coverage among people aged 60 years and above was 11.1% (range: 0.01-65.8%), with high variation among countries. For people aged 80 years and above, the median coverage was 16.3% (range: 0.01-88.2%), with high variation among countries. - Among the 24 reporting countries, three countries reported a vaccination coverage ≥50% for the age group 60 years and above, while eight countries reported a vaccination coverage ≥50% for the age group 80 years and above. - Most of the approximately 22.7 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Comirnaty Omicron XBB.1.5 (Pfizer BioNTech) vaccine (around 22 million doses; 97% of the total doses administered). - These preliminary results must be interpreted with caution. A higher degree of data consolidation and data completeness is expected in the coming weeks and months